HAVCR2 and acute myeloid leukemia: TIM-3, highly expressed on AML LSCs but absent in healthy HSCs, drives self-renewal through an autocrine loop that involves galectin-9 and the downstream activation of the ERK, AKT, and NFκB signaling pathways [161,162].